<--- Back to Details
First PageDocument Content
Aging-associated diseases / Intensive care medicine / Myocardial infarction / Acute coronary syndrome / Cirrhosis / Sepsis / Methicillin-resistant Staphylococcus aureus / Coronary artery disease / Percutaneous coronary intervention / Medicine / Health / Medical emergencies
Date: 2015-02-04 07:40:33
Aging-associated diseases
Intensive care medicine
Myocardial infarction
Acute coronary syndrome
Cirrhosis
Sepsis
Methicillin-resistant Staphylococcus aureus
Coronary artery disease
Percutaneous coronary intervention
Medicine
Health
Medical emergencies

Abstracts of Dissertations

Add to Reading List

Source URL: www.hkcp.org

Download Document from Source Website

File Size: 242,35 KB

Share Document on Facebook

Similar Documents

Protecting Newborns by Expanding Locally Manufactured QualityAssured Medicines The use of chlorhexidine gel on newborns is effective in preventing life-threatening sepsis and umbilical cord infections.

DocID: 1vlUr - View Document

Hacettepe’de Dünya Sepsis Günü Etkinliği, Basında sıklıkla yer alan yoğun bakımdaki hasta ölümlerinin temel nedenlerinden biri olan sepsis, hem gelişmekte olan hem de gelişmiş ülkelerde sık görülen an

DocID: 1vgeY - View Document

IMPROVING PEDIATRIC SEPSIS OUTCOMES A multi-year collaborative for children’s hospitals to reduce sepsis mortality and morbidity across all levels of care. WHAT’S INSIDE Executive Summary.............................

DocID: 1vbKE - View Document

Frequently Asked Questions  What is IPSO? The IPSO (Improving Pediatric Sepsis Outcomes) is a quality improvement collaborative of children’s hospitals addressing diagnosis and treatment across the hospital. IPSO ai

DocID: 1vajS - View Document

2018 年 5 月 30 放送 「Sepsis-3 における敗血症管理」 名古屋大学大学院 救急・集中治療医学教授

DocID: 1v1xA - View Document